PCSA Stock Analysis: Buy, Sell, or Hold?
PCSA - Processa Pharmaceuticals, Inc. Common
$1.68
0.06 (4.02%)
▲
5d:
+24.44%
30d:
-9.19%
90d:
-27.27%
WAIT
LOW Confidence
Analysis Updated: Oct 15, 2026 12:00 AM ET
Earnings: Nov 05, 2026
19d
Get Alerted When PCSA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: PCSA shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: PCSA shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: PCSA is currently trading at $1.68, which is considered oversold relative to its 30-day fair value range of $1.61 to $2.04.
Technical Outlook: Technically, PCSA is in a downtrend. Immediate support is located at $1.04, while resistance sits at $1.98. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: PCSA scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.00 (+1388.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, PCSA is in a downtrend. Immediate support is located at $1.04, while resistance sits at $1.98. The stock is showing strong short-term momentum, up 4.0% recently.
Market Sentiment: PCSA scores 72/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $25.00 (+1388.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.61 -
$2.04
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (72/100)
- BULLISH: Strong upward momentum (+4.0%)
- BULLISH: Trading 1388.1% below Wall St target ($25.00)
- WARNING: Composite score 48/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.61 -
$2.04
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.04
Resistance Level
$1.98
Current Trend
Downtrend
Technical data as of
Oct 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.45
Wall Street Target
$25.00
(+1388.1%)
Share & Embed Analysis
Last updated: October 16, 2026 9:33 AM ET
Data refreshes hourly during market hours. Next update: 10:33 AM
Data refreshes hourly during market hours. Next update: 10:33 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PCSA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
24 analysts |
$259 | 58 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
24 analysts |
$84 | 70 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
20 analysts |
$95 | 50 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$73 | 51 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
